MEMBRANOUS NEPHROPATHY

Clinical trials for MEMBRANOUS NEPHROPATHY explained in plain language.

Never miss a new study

Get alerted when new MEMBRANOUS NEPHROPATHY trials appear

Sign up with your email to follow new studies for MEMBRANOUS NEPHROPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 8 Not yet recruiting 1 Not yet finished but already full! 1 Completed 3 Terminated 1

New drug trial targets root cause of multiple serious kidney diseases

Disease control Ongoing

This study is testing a new drug called povetacicept in adults with several serious autoimmune kidney diseases, including lupus nephritis and IgA nephropathy. The main goals are to see if the drug is safe and if it can help control these diseases. Participants receive injections …

Matched conditions: MEMBRANOUS NEPHROPATHY

Phase: PHASE1, PHASE2 • Sponsor: Alpine Immune Sciences, Inc. • Aim: Disease control

Last updated Mar 25, 2026 14:08 UTC

MEMBRANOUS NEPHROPATHY

Get alerted when new MEMBRANOUS NEPHROPATHY trials appear

New drug trial targets root cause of multiple serious kidney diseases